Changeflow GovPing Government & Legislation Mercury Study in Pediatric Patients, Dental Ama...
Routine Notice Added Final

Mercury Study in Pediatric Patients, Dental Amalgam Exposure

Favicon for www.regulations.gov Regulations.gov Final Notices
Detected
Email

Summary

FDA filed a study submission to regulations.gov (FDA-2026-P-4271-0040) concerning mercury exposure from dental amalgam in pediatric patients. The document was posted to regulations.gov and contains a PDF download link, but the actual study content is not visible in the source text. This appears to be a pre-submission study or report filed under FDA's regulatory submissions system.

Published by FDA on regulations.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

This feed pulls every final notice posted to regulations.gov across all federal agencies, around 240 a month. Final notices are the binding step in the federal rulemaking cycle: a final rule, a no-action determination, a self-regulatory organization rule change, or a procedural notice that takes effect on publication. Watch this for the actionable end of the rulemaking pipeline rather than the proposed-and-comment phase. GovPing publishes each notice with the issuing agency, docket ID, effective date where stated, and document type. Recent examples include Nasdaq ISE auction rule changes and an NYSE proposal enabling tokenized securities trading under the DTC pilot.

What changed

FDA posted a study submission to regulations.gov regarding mercury exposure from dental amalgam in pediatric patients. The document (FDA-2026-P-4271-0040) contains only a PDF download link, with no study content visible in the source text. Healthcare providers and dental professionals should be aware that FDA has a filed study addressing mercury levels in children related to dental amalgam restorations. While the full study content is not accessible in this source, this filing indicates ongoing FDA activity in this regulatory area.

Affected parties including dental healthcare providers, pediatric healthcare professionals, and public health authorities should monitor regulations.gov for the full study document. This filing may inform future FDA guidance or regulatory actions regarding dental amalgam use in pediatric populations. The study's findings could impact clinical practices and regulatory standards for mercury-containing dental materials in children's dental care.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Content

Download File

Download

Get daily alerts for Regulations.gov Final Notices

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from FDA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
FDA
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
FDA-2026-P-4271-0040
Docket
FDA-2026-P-4271

Who this affects

Applies to
Healthcare providers Patients
Industry sector
6211 Healthcare Providers
Activity scope
Mercury exposure assessment Dental treatment safety
Geographic scope
United States US

Taxonomy

Primary area
Public Health
Operational domain
Clinical Operations
Topics
Public Health

Get alerts for this source

We'll email you when Regulations.gov Final Notices publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!